24-Month Efficacy of Viscodilation of Schlemm’s Canal and the Distal Outflow System with iTrack Ab-Interno Canaloplasty for the Treatment of Primary Open-Angle Glaucoma
Open Access
- 1 April 2021
- journal article
- research article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 15, 1591-1599
Abstract
Purpose: This study aimed to evaluate the 24-month efficacy of viscodilation of Schlemm’s canal and the distal outflow system with iTrack ab-interno canaloplasty in reducing intraocular pressure (IOP) and antiglaucoma medication use in patients with primary open-angle glaucoma (POAG). Patients and Methods: This retrospective, comparative, and consecutive case series assessed the 24-month outcomes of iTrack as a standalone procedure (iTrack-alone) or in conjunction with cataract surgery (iTrack+phaco), in cases of mild, moderate or severe POAG. Data were collected at baseline and the 12- and 24-month follow-up visits. Results: The study included 53 patients (60 eyes) with a mean age of 73.6± 9 years. For all eyes, a significant reduction in mean IOP was seen at 12 and 24 months, reducing from 20± 4.9 mmHg at baseline to 13.6± 1.9 mmHg and 13.5± 2.6 mmHg, respectively (P< 0.001). The reduction in medications was also significant, reducing to 1.12± 1.09 and 1.7± 1.29 medications at 12 months and 24 months, respectively, from a baseline of 2.77± 0.91 (P< 0.001). Similar results were achieved whether iTrack was performed as a standalone procedure, or in conjunction with cataract surgery. While the iTrack-alone group started with a higher IOP at baseline, both groups experienced similar and stable IOP reduction of more than 30% from baseline. The reduction in medication use was also significant in both groups, decreasing from 3± 0.7 for iTrack-alone and 2.5± 1.1 for iTrack+phaco at baseline to 2.1± 1.3 and 1.3± 1.2 at 24 months, respectively (P< 0.001). The 24-month efficacy outcomes were similar in cases of mild–moderate versus severe glaucoma. No serious adverse events were recorded. Conclusion: Twenty-four-month follow-up data demonstrate that iTrack ab-interno canaloplasty can effectively reduce IOP and medication dependence, with a good safety profile. These results also demonstrate that iTrack can be effectively performed as a standalone procedure or in combination with cataract surgery, and in all grades of glaucoma severity.Keywords
This publication has 16 references indexed in Scilit:
- Analysis and Modeling of Anatomical Changes of the Anterior Segment of the Eye After Cataract Surgery with Consideration of Different Phenotypes of Eye StructureCurrent Eye Research, 2014
- Anatomic Changes in Schlemm's Canal and Collector Channels in Normal and Primary Open-Angle Glaucoma Eyes Using Low and High Perfusion PressuresInvestigative Ophthalmology & Visual Science, 2014
- Aqueous outflow: Segmental and distal flowJournal of Cataract & Refractive Surgery, 2014
- Spectral-Domain Optical Coherence Tomographic Assessment of Schlemm's Canal in Chinese Subjects with Primary Open-angle GlaucomaOphthalmology, 2013
- Clinical Evaluation of the Aqueous Outflow System in Primary Open-Angle Glaucoma for CanaloplastyInvestigative Ophthalmology & Visual Science, 2010
- Cataract surgery to lower intraocular pressureMiddle East African Journal of Ophthalmology, 2009
- The number of people with glaucoma worldwide in 2010 and 2020British Journal of Ophthalmology, 2006
- Effects of viscoelastic injection into Schlemm’s canal in primate and human eyesOphthalmology, 2002
- Viscocanalostomy for open-angle glaucoma in black African patientsJournal of Cataract & Refractive Surgery, 1999
- Schlemm 's Canal and Primary Open Angle Glaucoma: Correlation Between Schlemm 's Canal Dimensions and Outflow FacilityExperimental Eye Research, 1996